Dose Optimization of Cefpirome Based on Population Pharmacokinetics and Target Attainment during Extracorporeal Membrane Oxygenation-Reference-Cited by-同舟云学术

Dose Optimization of Cefpirome Based on Population Pharmacokinetics and Target Attainment during Extracorporeal Membrane Oxygenation

Published:2020-04-21 Issue:5 Volume:64 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Kang Soyoung¹,Jang June Young²,Hahn Jongsung²,Kim Dasohm¹,Lee Jun Yeong³,Min Kyoung Lok¹,Yang Seungwon²³,Wi Jin⁴⁵,Chang Min Jung¹²³

Affiliation:

1. Department of Pharmaceutical Medicine and Regulatory Science, Yonsei University, Incheon, Republic of Korea

2. Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon, Republic of Korea

3. Graduate Program of Industrial Pharmaceutical Science, Yonsei University, Incheon, Republic of Korea

4. Division of Cardiology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea

5. Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea

Abstract

To obtain the optimal dosage regimen in patients receiving extracorporeal membrane oxygenation (ECMO), we developed a population pharmacokinetics model for cefpirome and performed pharmacodynamic analyses. This prospective study included 15 patients treated with cefpirome during ECMO. Blood samples were collected during ECMO (ECMO-ON) and after ECMO (ECMO-OFF) at predose and 0.5 to 1, 2 to 3, 4 to 6, 8 to 10, and 12 h after cefpirome administration. The population pharmacokinetic model was developed using nonlinear mixed effects modeling and stepwise covariate modeling.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00249-20

Reference52 articles.

1. Extracorporeal life support devices and strategies for management of acute cardiorespiratory failure in adult patients: a comprehensive review

2. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis

3. Extracorporeal Membrane Oxygenation Support in Refractory Cardiogenic Shock: Treatment Strategies and Analysis of Risk Factors

4. Nosocomial infections acquired by patients treated with extracorporeal membrane oxygenation;Austin DE;Crit Care Resusc,2017

5. Defining risk for infectious complications on extracorporeal life support

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics of antibacterial agents in the older population: a literature review;Expert Review of Clinical Pharmacology;2024-01-02

2. Thiazole, a privileged scaffold in drug discovery;Privileged Scaffolds in Drug Discovery;2023

3. Dose Optimization of Meropenem in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation in Critically Ill Cardiac Patients: Pharmacokinetic/Pharmacodynamic Modeling;Journal of Clinical Medicine;2022-11-08

4. Dose optimization of β-lactams antibiotics in pediatrics and adults: A systematic review;Frontiers in Pharmacology;2022-09-21

5. Pharmacokinetics and Time above the MIC Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO);International Journal of Antimicrobial Agents;2022-07